Manistee Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Trial of MTX101 2mg for the Acute Treatment of Migraine in Adults (NCT06728553) | Manistee Therapeutics | 2025-02-24 |
Track Manistee Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.